Drawing based on the description in the official product monograph. No photo yet.
“15 mg tablet is a white, biconvex, round film-coated tablet that is approximately 6 mm in diameter, with "A5" debossed on one side”
A5 pill
Pill with imprint A5 is white, round, 6 mm and has been identified as Ponatinib Hydrochloride 15 mg. It is used for myeloid leukemia. It is supplied by Takeda Pharmaceuticals U.s.a., Inc.
Sold in Canada
Ponatinib Hydrochloride 15 mg
- Brand
- Iclusig
- Imprint
- A5
- Strength
- 15 mg
- Used for
- Myeloid leukemia
- Color
- White
- Shape
- Round
- Size
- 6 mm
- Form
- Tablet
- Manufacturer
- Takeda Pharmaceuticals U.s.a., Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02437333
Source: Health Canada's Drug Product Database and the official product monograph. Last checked .
Report a mistake
What is Ponatinib Hydrochloride used for?
Ponatinib Hydrochloride is used for myeloid leukemia.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
ICLUSIG® is indicated for the treatment of adult patients with:
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
- Newly diagnosed Ph+ ALL in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s).
- As monotherapy in Ph+ ALL for whom no other kinase inhibitors are indicated or T315I-positive Ph+ ALL.
Chronic Myeloid Leukemia (CML)
- Chronic phase (CP) CML with resistance or intolerance to at least two prior kinase inhibitors.
- Accelerated phase (AP) or blast phase (BP) CML for whom no other kinase inhibitors are indicated.
- T315I-positive CML (chronic phase, accelerated phase, or blast phase).
Limitations of Use: ICLUSIG is not indicated and is not recommended for the treatment of patients with newly diagnosed CP-CML.
From the FDA-approved label on DailyMed (published Aug 19, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows A5.
- It is white, round, 6 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold in Canada as Iclusig by Takeda Pharmaceuticals U.s.a., Inc..
In Canada: prescription only.
Ingredients
Active: Ponatinib (Ponatinib Hydrochloride)
Other pills with imprint A 5
Same imprint, different listing. Check the color, size and maker against your pill.
-
A5
Amlodipine Besylate 5 mg
White, round, 2 mm
Used for high blood pressure and heart disease
-
A5
Frovatriptan Succinate 2.5 mg
White, round, 7 mm
Used for migraine
- A 5 Amlodipine Besylate 5 mg White, capsule Used for high blood pressure and heart disease
- A5 Amphetamine 15.7 mg Orange, round, 6 mm Used for ADHD and narcolepsy Schedule II
- A5 Amphetamine Extended-Release 15.7 mg Orange, round, 6 mm Used for ADHD Schedule II
- A5 Aripiprazole 5 mg Blue, rectangle, 8 mm Used for schizophrenia
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
par 256 MINOXIDIL 2 1 2
Minoxidil 2.5 mg
White, round, 7 mm
Used for severe high blood pressure and hair loss
-
L1
Colchicine Tablets 0.5 Mg 0.5 mg
White, round, 6 mm
-
C83
Dipyridamole 75 mg
White, round, 6 mm
-
C82
Dipyridamole 50 mg
White, round, 6 mm
-
C81
Dipyridamole 25 mg
White, round, 6 mm
-
AA 91
Albuterol 2 mg
White, round, 6 mm
Used for asthma and bronchial spasm
Other Ponatinib Hydrochloride pills
- NZ Ponatinib Hydrochloride 10 mg White, oval, 7 mm Used for myeloid leukemia
- A5 Ponatinib Hydrochloride 15 mg White, round, 6 mm Used for myeloid leukemia
- C7 Ponatinib Hydrochloride 30 mg White, round, 8 mm Used for myeloid leukemia
- AP4 Ponatinib Hydrochloride 45 mg White, round, 10 mm Used for myeloid leukemia